Passkey Therapeutics

Health Care · Locks, Safes & Home Security Products

Facts

as of Nov 18, 2026

Passkey’s Locksmith platform uses AI to identify synergistic drug combinations from approved assets using human genetic data; enabling clinical-stage innovation from day one.

Headquarters
Cambridge, United States
Employees
5US Form 5500 (plan participants) · Dec 2025 · -71% in a year

These are the key facts about Passkey Therapeutics on Alion as of Nov 18, 2026. Passkey Therapeutics is headquartered in Cambridge, United States. The latest round is Seed of $20M, announced in 2024.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Cambridge United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$20MTotal raised
SeedLatest round
1Rounds and grants
Money by yearUSD, rounds and grants
2024$20M1 record
Largest rounds and grants
2024
$20M
Sources: funding announcements, grant and company registers

Money

Passkey Therapeutics has $20M paid in by investors, lenders and donors.

$20MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised
Oct 2024 · Seed
$20MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Milestones

Each milestone is dated by its source: registers, filings, the press